# Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck

> **NIH NIH R01** · EMORY UNIVERSITY · 2024 · $48,916

## Abstract

PROJECT SUMMARY/ABSTRACT
Not Requested

## Key facts

- **NIH application ID:** 11064397
- **Project number:** 3R01CA262123-02S1
- **Recipient organization:** EMORY UNIVERSITY
- **Principal Investigator:** DONG M SHIN
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $48,916
- **Award type:** 3
- **Project period:** 2023-04-18 → 2025-03-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/11064397

## Citation

> US National Institutes of Health, RePORTER application 11064397, Personalized vaccine immunotherapy in combination with anti-PD 1 antibody for recurrent or metastatic squamous cell carcinoma of the head and neck (3R01CA262123-02S1). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/11064397. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*